Bone marrow mesenchymal stem cell-derived exosomal miR-30e-5p ameliorates high-glucose induced renal proximal tubular cell pyroptosis by inhibiting ELAVL1

References

• Moţa E, Panduru MN, Popa SG, et al. Risk factors for diabetic nephropathy: intrinsic or extrinsic renal? Rom J Intern Med. 2009;47(4):397–401.
   PubMedGoogle Scholar
• Toth-Manikowski S, Atta MG. Diabetic kidney disease: pathophysiology and therapeutic targets. J Diabetes Res. 2015;2015:697010.
   PubMed Web of Science ®Google Scholar
• Ebrahim N, Ahmed IA, Hussien NI, et al. Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells. 2018;7(12):226.
   PubMed Web of Science ®Google Scholar
• Khalilpourfarshbafi M, Hajiaghaalipour F, Selvarajan KK, et al. Mesenchymal stem cell-based therapies against podocyte damage in diabetic nephropathy. Tissue Eng Regen Med. 2017;14(3):201–210.
   PubMed Web of Science ®Google Scholar
• Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63.
   PubMed Web of Science ®Google Scholar
• Zou L, Ma X, Lin S, et al. Bone marrow mesenchymal stem cell-derived exosomes protect against myocardial infarction by promoting autophagy. Exp Ther Med. 2019;18(4):2574–2582.
   PubMed Web of Science ®Google Scholar
• Li G, Peng H, Qian S, et al. Bone marrow-derived mesenchymal stem cells restored high-fat-fed induced hyperinsulinemia in rats at early stage of type 2 diabetes mellitus. Cell Transplant. 2020;29:963689720904628.
   PubMed Web of Science ®Google Scholar
• Lee SE, Jang JE, Kim HS, et al. Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells. Exp Mol Med. 2019;51(7):1–14.
   Google Scholar
• Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci. 2020;111(9):3100–3110.
   PubMed Web of Science ®Google Scholar
• Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–593.
   PubMed Web of Science ®Google Scholar
• Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14(3):5338–5366.
   PubMed Web of Science ®Google Scholar
• Bhatt K, Kato M, Natarajan R. Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases. Am J Physiol Renal Physiol. 2016;310(2):F109–F118.
   PubMed Web of Science ®Google Scholar
• Nascimento LRD, Domingueti CP. MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease. J Bras Nefrol. 2019;41(3):412–422.
   PubMedGoogle Scholar
• Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, et al. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein. Cancer Lett. 2015;356(2 Pt B):597–605.
   PubMed Web of Science ®Google Scholar
• Mao J, Hu X, Pang P, et al. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway. Oncol Rep. 2017;38(1):393–401.
   PubMed Web of Science ®Google Scholar
• Laudato S, Patil N, Abba ML, et al. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1. Int J Cancer. 2017;141(9):1879–1890.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng ZJ, Jia YJ, et al. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. J Transl Med. 2018;16(1):146.
   PubMedGoogle Scholar
• Delić D, Eisele C, Schmid R, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PLOS One. 2016;11(3):e0150154.
   PubMed Web of Science ®Google Scholar
• Coll NS, Epple P, Dangl JL. Programmed cell death in the plant immune system. Cell Death Differ. 2011;18(8):1247–1256.
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99–109.
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99–114.
   PubMed Web of Science ®Google Scholar
• Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–335.
   PubMed Web of Science ®Google Scholar
• Shi Q, Lee DY, Feliers D, et al. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease. Mol Metab. 2020;36:100968.
   PubMed Web of Science ®Google Scholar
• Fan J, Xie K, Wang L, et al. Roles of inflammasomes in inflammatory kidney diseases. Mediators Inflamm. 2019;2019:2923072.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Z. Effect and regulation of the NLRP3 inflammasome during renal fibrosis. Front Cell Dev Biol. 2019;7:379.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Zhong Z, Zhang Y, et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-335-5p attenuates the inflammation and tubular epithelial–myofibroblast transdifferentiation of renal tubular epithelial cells by reducing ADAM19 protein levels. Stem Cell Res Ther. 2022;13(1):373.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang D, Tang B, et al. Exosomes from human umbilical cord mesenchymal stem cells reduce damage from oxidative stress and the epithelial–mesenchymal transition in renal epithelial cells exposed to oxalate and calcium oxalate monohydrate. Stem Cells Int. 2019;2019:6935806.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.
   PubMed Web of Science ®Google Scholar
• Konari N, Nagaishi K, Kikuchi S, et al. Mitochondria transfer from mesenchymal stem cells structurally and functionally repairs renal proximal tubular epithelial cells in diabetic nephropathy in vivo. Sci Rep. 2019;9(1):5184.
   PubMedGoogle Scholar
• Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A. 2006;103(46):17438–17443.
   PubMed Web of Science ®Google Scholar
• Lv S, Cheng J, Sun A, et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress. Diabetes Res Clin Pract. 2014;104(1):143–154.
   PubMed Web of Science ®Google Scholar
• Zhou H, Tian HM, Long Y, et al. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Chin Med J. 2009;122(21):2573–2579.
   PubMed Web of Science ®Google Scholar
• Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336.
   PubMed Web of Science ®Google Scholar
• Hu W, Han Q, Zhao L, et al. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-beta1. J Cell Physiol. 2019;234(2):1469–1476.
   PubMed Web of Science ®Google Scholar
• Ban E, Jeong S, Park M, et al. Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity. Biomed Pharmacother. 2020;121:109613.
   PubMed Web of Science ®Google Scholar
• Mamun A, Ara Mimi A, Wu A, et al. Pyroptosis in diabetic nephropathy. Clin Chim Acta. 2021;523:131–143.
   PubMed Web of Science ®Google Scholar
• Lin J, Cheng A, Cheng K, et al. New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci. 2020;21(19):7057.
   PubMed Web of Science ®Google Scholar
• Wang H, Huang S, Hu T, et al. Circ_0000064 promotes high glucose-induced renal tubular epithelial cells injury to facilitate diabetic nephropathy progression through miR-532-3p/ROCK1 axis. BMC Endocr Disord. 2022;22(1):67.
   PubMed Web of Science ®Google Scholar
• Lin CY, Lin YC, Paul CR, et al. Isoliquiritigenin ameliorates advanced glycation end-products toxicity on renal proximal tubular epithelial cells. Environ Toxicol. 2022;37(8):2096–2102.
   PubMed Web of Science ®Google Scholar
• Kim D, Nam GY, Seo E, et al. Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells. J Biomed Sci. 2022;29(1):31.
   PubMed Web of Science ®Google Scholar
• Ma T, Li X, Zhu Y, et al. Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis. Front Immunol. 2022;13:835879.
   PubMed Web of Science ®Google Scholar
• Xu Y, Gao H, Hu Y, et al. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway. Exp Cell Res. 2019;382(2):111463.
   PubMed Web of Science ®Google Scholar
• Chen D, Liu Y, Chen J, et al. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. Eur J Pharmacol. 2021;902:174121.
   PubMed Web of Science ®Google Scholar
• Fu J, Lee K, Chuang PY, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2015;308(4):F287–F297.
   PubMed Web of Science ®Google Scholar